Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Olympus America Licenses Patents to BioImagene
Jul 2010
CENTER VALLEY, Pa., July 26, 2010 — BioImagene Inc. and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement that allows BioImagene to access Olympus’ patent portfolio in the field of digital pathology and virtual microscopy.

The license is the most recent that Olympus has granted for the technologies, which are critical for developing future digital imaging and data handling systems for pathology.

Digital pathology technologies offer the potential to change the way doctors review and manage biopsy slides and other pathology specimens handled using glass slides and traditional optical microscopes. The patents included in the deal will cover methods and equipment for creating, storing and delivering virtual microscopy slides.

The technology will enable pathologists to view and share high-resolution virtual microscopy images via the Internet.

No specific terms or conditions were made public.

Located in Sunnyvale, Calif., BioImagene provides scalable digital pathology solutions for diagnostics.

For more information, visit: 

An instrument consisting essentially of a tube 160 mm long, with an objective lens at the distant end and an eyepiece at the near end. The objective forms a real aerial image of the object in the focal plane of the eyepiece where it is observed by the eye. The overall magnifying power is equal to the linear magnification of the objective multiplied by the magnifying power of the eyepiece. The eyepiece can be replaced by a film to photograph the primary image, or a positive or negative relay...
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.